OX40: targeted immunotherapy--implications for tempering autoimmunity and enhancing vaccines.

Weinberg, Andrew D

OX40: targeted immunotherapy--implications for tempering autoimmunity and enhancing vaccines. [electronic resource] - Trends in immunology Feb 2002 - 102-9 p. digital

Publication Type: Journal Article; Review

1471-4906

10.1016/s1471-4906(01)02127-5 doi


Animals
Autoimmunity--immunology
Humans
Immunotherapy
Membrane Glycoproteins--immunology
OX40 Ligand
Receptors, OX40
Receptors, Tumor Necrosis Factor
T-Lymphocytes--immunology
Tumor Necrosis Factor Receptor Superfamily, Member 7--immunology
Vaccines--immunology